FDA OK's Ozempic To Protect Kidneys in Type 2 Diabetes Patients

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 29, 2025.

By India Edwards HealthDay Reporter

WEDNESDAY, Jan. 29, 2025 -- A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans at risk for kidney failure.

The U.S. Food and Drug Administration (FDA) has officially approved Ozempic to help reduce the risk of serious kidney complications in people with Type 2 diabetes and chronic kidney disease.

Type 2 diabetes is a leading cause of chronic kidney disease, which affects more than 1 in 7 U.S. adults. The new approval allows doctors to prescribe Ozempic specifically to lower the risk of kidney failure, dialysis and death from heart-related problems in these high-risk patients.

“Over the last 20 years, it’s been an area where researchers tried hard but delivered very little,” Dr. Stephen Gough, senior vice president of global medical affairs at Novo Nordisk, the company that makes Ozempic, told The New York Times. “To have something new like this is really exciting, and offers promise to patients.”

Doctors already use Ozempic to manage Type 2 diabetes and reduce the risk of heart disease in diabetic patients. This move, as reported by The Times, was based on research showing that people with both Type 2 diabetes and chronic kidney disease who took Ozempic had a 24% lower risk of kidney-related complications, such as needing dialysis or an organ transplant.

Patients in the study also had slower rates of kidney decline and were less likely to die from heart problems.

“The more we can delay the decline in kidney function, the better,” Dr. Melanie Hoenig, a kidney specialist at Beth Israel Deaconess Medical Center in Boston, told The Times.

Ozempic is often referred to as a "weight loss" drug, but it is not officially approved for that purpose. It is mainly used to control blood sugar, but researchers suspect the drug may also reduce inflammation in the kidneys and throughout the body.

Doctors often prescribe medications to lower blood pressure, blood sugar and cholesterol to help protect the kidneys, but treatment options are still limited.

With Ozempic’s approval for kidney disease, though, demand for the drug is expected to grow, and Novo Nordisk has already struggled to keep up.

What's more, the FDA lists semaglutide, the compound in Ozempic and the weight loss drug Wegovy, as currently in shortage.

“Many people, unfortunately, cannot get it,” Hoenig told The Times. “But if they can and it works for them, and they can tolerate it, it’s a wonderful thing to have more tools.”

Sources

  • The New York Times, media report, Jan. 28, 2025: U.S. Food and Drug Administration, drug shortage database

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-01-30 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords